Latest California Healthline Stories
KFF Health News' 'What the Health?': Congress Is Out. The Presidential Campaign Is In.
Congress is in recess until after Labor Day, and lawmakers won’t have much time when they return to get the government funded before the next fiscal year. Meanwhile, the Republican campaign for president has begun in earnest, and while repealing the Affordable Care Act is no longer the top promise, some candidates have lively ideas about what to do with federal health programs. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Lauren Weber of The Washington Post join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews KFF Health News’ Phil Galewitz, who reported the latest KFF Health News-NPR “Bill of the Month,” about how a bill that should never have been sent created headaches for one patient.
As Pandemic Emergencies End, People Battling Long Covid Feel ‘Swept Under the Rug’
Millions of Americans suffer from long covid, which can have debilitating physical effects, including fatigue and difficulty breathing. Yet many patients feel they’re on their own.
KHN’s ‘What the Health?’: The Covid Response Coordinator Speaks
Can’t see the audio player? Click here to listen on Acast. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you listen to podcasts. Click here for a transcript of the episode. Dr. Ashish Jha, the White House covid-19 response coordinator, is the guest for a wide-ranging interview on this week’s […]
The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice.
Private equity-backed Headlands Research heralded its covid-19 vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.
Para lanzar un nuevo fármaco al mercado, la Administración de Alimentos y Medicamentos (FDA) exige a las farmacéuticas estudios exhaustivos para demostrar su seguridad y eficacia. Conseguir que un medicamento salga al mercado unos meses antes, y con menos gastos de lo habitual, puede traducirse en beneficios millonarios para el fabricante.
Treating Long Covid Is Rife With Guesswork
With a dearth of evidence on effective treatments for long covid, patients and doctors in 400 clinics around the country still rely on trial and error.
KHN’s ‘What the Health?’: The Midterm Shake-Up
Can’t see the audio player? Click here to listen on Acast. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you listen to podcasts. Click here for a transcript of the episode. The predicted Republican “red wave” was a no-show in this week’s midterm elections, but the margins in both the […]
People With Long Covid Face Barriers to Government Disability Benefits
Some people with long covid have fallen through the cracks of the government’s disability system, which was time-consuming and difficult to navigate even before the pandemic.
Unraveling the Interplay of Omicron, Reinfections, and Long Covid
The omicron variant has proved adept at finding hosts, often by reinfecting people who recovered from earlier bouts of covid. But whether omicron triggers long covid as often and severe as previous variants is a matter of heated study.
Cognitive Rehab May Help Older Adults Clear Covid-Related Brain Fog
People whose brains have been injured by concussions, traumatic accidents, strokes, or neurodegenerative conditions such as Parkinson’s disease can benefit from targeted therapy. Experts also employ therapies for long-covid patients with memory and language problems.